A carregar...
Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction
Interleukin 6 receptor (IL6R) inhibitor, tocilizumab, has been effectively used in the treatment of cytokine release syndrome in patients receiving chimeric antigen receptor T-cell therapy. Here we present a patient with chronic myelomonocytic leukemia (CMML) who developed a steroid refractory, post...
Na minha lista:
| Publicado no: | Leuk Res Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672312/ https://ncbi.nlm.nih.gov/pubmed/33240789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2020.100228 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|